Literature DB >> 6546292

A consideration of the hormonal basis and phosphate leak hypothesis of absorptive hypercalciuria.

A E Broadus, K L Insogna, R Lang, L E Mallette, D A Oren, J M Gertner, A S Kliger, A F Ellison.   

Abstract

Fifty patients with absorptive hypercalciuria (AH), 25 normal subjects (NS), and 25 nonhypercalciuric patients with stone disease (NHSF) were studied using an oral calcium tolerance test and 24-h urine collections on both a restricted and an unrestricted calcium intake. Mean (+/- SD) fasting fractional calcium excretion was increased in the patients with AH (2.7 +/- 1.1% vs. 1.4 +/- 0.6% in the NS; P less than 0.001) and was negatively correlated with fasting nephrogenous cAMP, suggesting that this renal calcium leak was secondary to parathyroid suppression. Plasma 1,25-dihydroxyvitamin D [1,25-(OH)2D] was elevated in 80% of patients with AH and was high normal in the remaining 20%. Ten patients, selected on the basis of results for 1,25-(OH)2D greater than 4 SD from the normal mean, displayed a particularly severe pattern of abnormalities, including mild hypercalcemia in two patients. Pooled data from the NS and patients with AH revealed a significant negative correlation between the plasma concentration of 1,25-(OH)2D and the renal phosphate threshold (r = -0.40; P less than 0.001), but this correlation lost significance when the NHSF were substituted for the NS as a control group (r = -0.07; P = NS). These findings 1) provide a pathophysiological basis for the increase in fasting calcium excretion commonly observed in hypercalciuric patients, and 2) stress the importance of circulating 1,25-(OH)2D in the pathogenesis of the syndrome, but 3) fail to support the phosphate leak theory of pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546292     DOI: 10.1210/jcem-58-1-161

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  [Peroral calcium administration test with free diet in idiopathic calcium nephrolithiasis--possibilities and limits].

Authors:  B Hess; A Winter; K Gautschi; U Binswanger
Journal:  Klin Wochenschr       Date:  1986-10-15

Review 2.  Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management.

Authors:  Khashayar Sakhaee; Naim M Maalouf; Bridget Sinnott
Journal:  J Clin Endocrinol Metab       Date:  2012-03-30       Impact factor: 5.958

Review 3.  Skeletal and extraskeletal disorders of biomineralization.

Authors:  Michael T Collins; Gemma Marcucci; Hans-Joachim Anders; Giovanni Beltrami; Jane A Cauley; Peter R Ebeling; Rajiv Kumar; Agnès Linglart; Luca Sangiorgi; Dwight A Towler; Ria Weston; Michael P Whyte; Maria Luisa Brandi; Bart Clarke; Rajesh V Thakker
Journal:  Nat Rev Endocrinol       Date:  2022-05-16       Impact factor: 47.564

4.  Evidence for a prostaglandin-mediated bone resorptive mechanism in subjects with fasting hypercalciuria.

Authors:  P Filipponi; C Mannarelli; R Pacifici; E Grossi; I Moretti; S Tini; C Carloni; A Blass; P Morucci; K A Hruska
Journal:  Calcif Tissue Int       Date:  1988-08       Impact factor: 4.333

5.  Classification of idiopathic hypercalciuric patients by isotopic calcium absorption: a comparison with oral calcium tolerance test.

Authors:  R Pacifici; P Filipponi; C Mannarelli; G Vespasiani; M Porena; L Fedeli; V Morucci; L V Avioli
Journal:  Calcif Tissue Int       Date:  1985-09       Impact factor: 4.333

Review 6.  Pathogenesis of idiopathic hypercalciuria: a review.

Authors:  E Vosburgh; T J Peters
Journal:  J R Soc Med       Date:  1987-01       Impact factor: 18.000

7.  Altered Calcium and Vitamin D Homeostasis in First-Time Calcium Kidney Stone-Formers.

Authors:  Hemamalini Ketha; Ravinder J Singh; Stefan K Grebe; Eric J Bergstralh; Andrew D Rule; John C Lieske; Rajiv Kumar
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.